Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.33
-2.92 %
$ 342 M
Market Cap
-5.32
P/E
1. INTRINSIC VALUE
FINANCIALS
Balance Sheet
SNDL Inc.
| Current Assets | 462 M |
| Cash & Short-Term Investments | 249 M |
| Receivables | 28.1 M |
| Other Current Assets | 185 M |
| Non-Current Assets | 887 M |
| Long-Term Investments | 437 M |
| PP&E | 261 M |
| Other Non-Current Assets | 189 M |
| Current Liabilities | 90.6 M |
| Accounts Payable | 27.1 M |
| Short-Term Debt | 34.3 M |
| Other Current Liabilities | 29.2 M |
| Non-Current Liabilities | 125 M |
| Long-Term Debt | 118 M |
| Other Non-Current Liabilities | 7.31 M |
EFFICIENCY
Earnings Waterfall
SNDL Inc.
| Revenue | 920 M |
| Cost Of Revenue | 680 M |
| Gross Profit | 240 M |
| Operating Expenses | 344 M |
| Operating Income | -104 M |
| Other Expenses | -7.61 M |
| Net Income | -96.2 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
SNDL Inc.
| Net Income | -96.2 M |
| Depreciation & Amortization | 56.7 M |
| Capital Expenditures | -11 M |
| Stock-Based Compensation | 20 M |
| Change in Working Capital | -7.45 M |
| Others | 83.8 M |
| Free Cash Flow | 43.9 M |
Wall Street Analysts Price Targets
SNDL Inc.
Wall Street analysts predict an average 1-year price target for SNDL of $2.26 , with forecasts ranging from
a
low of
$0.5 to a high of $3.6 .
SNDL Lowest Price Target
Wall Street Target
0.5 USD
-62.41%
SNDL Average Price Target
Wall Street Target
2.26 USD
69.92%
SNDL Highest Price Target
Wall Street Target
3.6 USD
170.68%
4. DIVIDEND
ANALYSIS
SNDL does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
SNDL Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Top Canadian Cannabis Stocks to Watch in April 2025
Top Canadian cannabis stocks are attracting attention this week as investors seek opportunities in a rapidly evolving industry. Companies like Cronos Group, SNDL Inc., and Aurora Cannabis continue strengthening their positions in Canadian and international markets. Though based in Canada, these firms have exposure to the U.S. through strategic investments and partnerships. The U.S. cannabis industry is expected to generate over $45 billion annually by 2025. Legalization efforts are expanding, and several states are reviewing new adult-use and medical cannabis bills. At the same time, court rulings and state-level decisions continue to shape the legal landscape. Because of this, Canadian companies with U.S. exposure are drawing increased interest from traders and long-term investors alike.
marijuanastocks.com
- 1 week ago
SNDL Stock: Despite The Weakness In Cannabis Sector, I Maintain My Buy Rating
SNDL reported a 3.7% increase in revenue YoY and a 20% increase in profit YoY. The company reported its highest revenue numbers and profit to date. SNDL stock is up 7.38% over the last twelve months.
seekingalpha.com
- 3 weeks ago
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end.
marijuanastocks.com
- 3 weeks ago
SNDL Inc. (SNDL) Q4 2024 Earnings Call Transcript
SNDL Inc. (NASDAQ:SNDL ) Q4 2024 Earnings Conference Call March 18, 2025 10:00 AM ET Company Participants Zach George - Chief Executive Officer Alberto Paredero-Quiros - Chief Financial Officer Conference Call Participants Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Hello, everyone, and welcome to SNDL Fourth Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.
seekingalpha.com
- 3 weeks ago
SNDL Reports Fourth Quarter and Full Year 2024 Financial and Operational Results
The Company reports Record Full Year Net Revenue, Gross Profit and Gross Margin, as well as positive Cash Flow and Free Cash Flow CALGARY, AB , March 18, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated.
prnewswire.com
- 3 weeks ago
Investing in Cannabis: Best Canadian Stocks to Watch in March 2025
The Canadian cannabis sector continues to evolve as companies expand operations and navigate industry challenges. Many Canadian cannabis producers are looking beyond their domestic market and establishing strong positions in the U.S. Despite federal restrictions. Some have developed partnerships, investments, or business strategies that position them well for eventual legalization.
marijuanastocks.com
- 1 month ago
SNDL to Announce Fourth Quarter 2024 and Full Year 2024 Financial Results on March 18, 2025
CALGARY, AB , Feb. 25, 2025 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2024 financial results for the period ended December 31, 2024, before market opens on Tuesday, March 18, 2025. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m.
prnewswire.com
- 1 month ago
These Marijuana Stocks Could Make The Difference In Your Portfolio
Marijuana stocks are in the same spot where the market is going to have issues with volatility. Due to the political landscape of passing federal reform or any cannabis laws, the next 4 years will be interesting. At this time most people inside Donald Trump's cabinet are not in favor of legal cannabis.
marijuanastocks.com
- 1 month ago
HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets
VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a collaboration agreement (the Agreement) with SNDL Inc. (NASDAQ: SNDL) ("SNDL"), one of the world's largest vertically integrated cannabis companies, to jointly develop Good Manufacturing Practices (GMP) compliant vape cartridges.
globenewswire.com
- 2 months ago
Top Canadian Cannabis Companies Poised for Market Growth in 2025
The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are projected to reach $50 billion by 2026. This impressive growth is fueled by increasing state-level legalization and the potential for federal reform. Recent headlines, including bipartisan efforts to reschedule cannabis and banking legislation advancements, have renewed investor optimism. As Canadian cannabis companies eye the lucrative U.S. market, their innovative strategies and cross-border partnerships position them for potential success. This week, top Canadian cannabis stocks, including Aurora Cannabis, Cronos Group, and Sundial Growers, are worth watching closely.
marijuanastocks.com
- 2 months ago
HYTN Announces Initial Purchase Order under Manufacturing Partnership with Industry-Leading SNDL
VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical company specializing in pharmaceutical-grade cannabis manufacturing is pleased to announce the receipt of an initial purchase order under manufacturing and pricing agreements (the Agreements) with SNDL Inc. (NASDAQ: SNDL) ("SNDL"), one of the world's largest vertically integrated cannabis companies. This collaboration underscores the Company's commitment to expanding its presence in regulated international markets, including the UK, Germany, and Australia.
globenewswire.com
- 2 months ago
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by 2025, legalization efforts are gaining traction. Recent news highlights growing bipartisan support for federal cannabis reform in the U.S., which could further boost industry expansion. Canadian cannabis companies, with their well-established infrastructure and international presence, are strategically positioned to capitalize on this growth. Tracking key stocks with solid fundamentals and technical setups becomes essential as investors look for potential gains.
marijuanastocks.com
- 3 months ago
8. Profile
Summary
SNDL Inc. SNDL
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 342 M
Dividend Yield
0.00%
Description
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Contact
919–11 Avenue SW, Calgary, AB, T2R 1P3
https://www.sndlgroup.com
IPO
Date
Aug. 1, 2019
Employees
2604
Officers
Mr. Navroop Sandhawalia
President of Liquor Division
Mr. Matthew Scott Husson
General Counsel & Corporate Secretary
Mr. Tyler Robson
President of Cannabis
Mr. Phil McBride
Chief Information Officer
Mr. Ryan Hellard
Chief Strategy Officer
Ms. Deanna Garand
Vice President of Human Resources
Mr. Zachary Ryan George IV
Chief Executive Officer & Non Independent Director
Mr. Alberto Paredero-Quiros
Chief Financial Officer